Back to Stocks
Rank #1010AXGN
AxoGen, Inc.
$35.01
-0.68% (Daily)
Market Cap
$1.76B
Revenue
$214.71M
Rank by MCap
#1010
Sector
Healthcare
Industry
Medical Devices
CEO
Mr. Michael D. Dale
Headquarters
Alachua, FL
Employees
451
About AxoGen, Inc.
Axogen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripher...
AxoGen, Inc. Price Chart
Loading chart…